DMRA Form 144: Proposed sales of Common Stock

DMRA provides a Form 144 notice listing proposed sales of Common Stock.

Rhea-AI Filing Summary

DMRA provides a Form 144 notice listing proposed sales of Common Stock. The filing names Maxim Group as broker and lists planned cash sales tied to option exercises dated 01/03/2025 and 10/09/2024. The reported lot sizes include 5,000, 5,787, and 7,213 shares.

The notice specifies Common Stock and shows a trading market of NASDAQ. The filing supplies broker contact information and the dates 06/22/2026 associated with the filing entries.

Insights

Securities Counsel

Rule 144 notice lists prospective cash sales from option exercises; compliance mechanics govern timing.

Form 144 is a notification that certain holders intend to sell restricted or control securities under Rule 144. The entry lists Common Stock, exercise dates of 01/03/2025 and 10/09/2024, and planned cash sales of 5,000, 5,787, and 7,213 shares.

Whether sales can occur depends on Rule 144 holding-period, volume limits, and current public information requirements. Subsequent filings will show executed transactions or adjustments to planned amounts.

Key Figures

Planned sale lot: 5,000 shares Planned sale lot: 5,787 shares Planned sale lot: 7,213 shares +2 more

5 metrics

Planned sale lot 5,000 shares Option exercise dated 01/03/2025

Planned sale lot 5,787 shares Option exercise dated 10/09/2024

Planned sale lot 7,213 shares Option exercise dated 10/09/2024

Filing date referenced 06/22/2026 Date associated with the filing entries

Broker Maxim Group (address listed) Broker for proposed sales

Key Terms

Form 144, Option, Cash

3 terms

Form 144 regulatory

"lists proposed sales of Common Stock and broker information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Option financial

"Common Stock | 01/03/2025 | Option | Issuer"

An option is a financial contract that gives its holder the right, but not the obligation, to buy or sell a stock at a specified price within a set time. Investors use options like a reservation or coupon to lock in a price, protect against losses, or amplify potential gains with a smaller upfront cost than owning the stock outright, making them useful for hedging, income strategies, or speculative bets.

Cash financial

"the planned sales are labeled 'CASH' in the securities lines"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does DMRA's Form 144 filing disclose?

The filing discloses proposed cash sales of Common Stock via Maxim Group. It lists option exercise dates 01/03/2025 and 10/09/2024 and shows planned lots of 5,000, 5,787, and 7,213 shares.

Who is the broker handling the proposed sales in DMRA's Form 144?

The filing names Maxim Group at 300 Park Ave, New York, as the broker. The entry pairs the broker with Common Stock proposed cash sales under the Form 144 notice.

Does the Form 144 state the market where DMRA shares trade?

Yes. The filing indicates the securities trade on NASDAQ, as shown in the securities information line accompanying the Form 144 entries.

Are the amounts in the Form 144 the number of shares to be sold?

The listed figures (5,000, 5,787, 7,213) are presented as lots associated with option exercises and planned cash sales in the Form 144 notice.

Does the Form 144 confirm the sales have already occurred?

No. Form 144 is a notice of proposed sales. The filing lists planned cash sales tied to option exercises but does not state that the transactions have been completed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/22/2026 - 02:27 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001808248
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Damora Therapeutics, Inc.
SEC File Number	001-39655
Address of Issuer	221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MASSACHUSETTS 02453
Phone	(781) 281-9020
Name of Person for Whose Account the Securities are To Be Sold	Firmani Lori
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Maxim Group 300 Park Ave 16th Floor New York NY 10022	7615	193140.00	61533194	06/22/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	01/03/2025	Option	Issuer			5000	06/22/2026	CASH
Common Stock	10/09/2024	Option	Issuer			5787	06/22/2026	CASH
Common Stock	10/09/2024	Option	Issuer			7213	06/22/2026	CASH

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	06/22/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Dominick Iadicicco, as a duly authorized representative of Maxim Group LLC., as attorney-in-fact for Lori Firmani
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)